title: Transplantation with pathologic kidneys to improve the pool of donors:  an example of shunt nephritis.
authors.forename: Florent
authors.initials: F
authors.lastname: Guerville
authors.forename: Sebastien
authors.initials: S
authors.lastname: Lepreux
authors.forename: Delphine
authors.initials: D
authors.lastname: Morel
authors.forename: Thomas
authors.initials: T
authors.lastname: Bachelet
authors.forename: Karine
authors.initials: K
authors.lastname: Moreau
authors.forename: Pierre
authors.initials: P
authors.lastname: Merville
authors.forename: Lionel
authors.initials: L
authors.lastname: Couzi
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000077552:Basiliximab; D017809:Fatal Outcome; D005919:Glomerular Filtration Rate / Q000502:physiology; D006801:Humans; D006849:Hydrocephalus / Q000473:pathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009394:Nephritis, Hereditary / Q000601:surgery*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors / Q000600:supply & distribution*; D016896:Treatment Outcome; D017287:Ventriculoperitoneal Shunt; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D009173:Mycophenolic Acid; D016559:Tacrolimus; D008775:Methylprednisolone